Deutsche Bank analyst Pito Chickering lowered the firm’s price target on Zimmer Biomet (ZBH) to $107 from $115 and keeps a Hold rating on the ...
Zimmer Biomet (NYSE: ZBH) shares dipped slightly today on fourth-quarter results that came in just ahead of the consensus ...
The S&P 500 Dividend Aristocrats Index pairs long-term results with versatility. We sell different types of products and services to both investment professionals and individual investors. These ...